Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azvudine for the Treatment of COVID-19
NCT04425772Phase 3Unknown
- Sponsor
- Genuine Biotech
- Start
- Jun 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of azvudine in coronavirus disease 2019 (COVID-19), sponsored by Genuine Biotech. Status: unknown.
02
Drugs
azvudine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04425772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04425772.